China’s Vaccine Giant CanSino Biologics Sees Net Profit Down 99%
Follow
0
41 views • September 11, 2022

https://gnews.org/post/p1jiy5cfa

09/10/2022 Spotlight on China: Chinese vaccine maker CanSino Biologics has reported earnings down sharply in the first half of this year, its net profit down 99%. But CanSino’s new COVID vaccine for inhalation was approved by Chinese authorities

Keywords
FREE email alerts of the most important BANNED videos in the world
Get FREE email alerts of the most important BANNED videos in the world that are usually blacklisted by YouTube, Facebook, Google, Twitter and Vimeo. Watch documentaries the techno-fascists don't want you to know even exist. Join the free Brighteon email newsletter. Unsubscribe at any time. 100% privacy protected.
Your privacy is protected. Subscription confirmation required.